Labcorp Holdings
LEI OZ7UA8IXAIFILY2VZH07
Upgrade to Premium features
Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market
Get access-
Full access to the largest bond database
Bond parameters,
prospectuses -
Seamless
Data exportAnalyze the data in the most efficient way
-
Bond pricing
Current & historical quotes from 400+ stock exchanges & OTC market
-
Smart risk assessment
Credit ratings, financial reports
Trading Schedule Issuer map
Quotes
- «
- 1
- ...
- {{ quotes.page - 2 }}
- {{ quotes.page - 1 }}
- {{ quotes.page }}
- {{ quotes.page + 1 }}
- {{ quotes.page + 2 }}
- ...
- {{ quotesLastPage }}
- »
Profile
|
Labcorp Holdings Inc. operates as a holding company. The Company, through its subsidiaries, specializes in providing clinical lab tests for allergies, genetics and genomics, colorectal cancer, diabetes, chronic kidney disease, and pregnancy, as well as clinical trials for oncology and COVID-19. Labcorp Holdings serves patients, biopharma, health system, and organization worldwide.
|
General information
-
Organization nameLabcorp Holdings Inc
-
Organization statusOperating organization
-
AddressC/O Treasury 531 South Spring Street Burlington, USA, 27215
-
Site
-
Previous organization nameLaboratory Corp of America Holdings (to 16/05/2024)
News
IFRS/US GAAP reports
| 2026 | |
| 2025 | |
| 2024 | |
| 2023 | |
| 2022 | |
| 2021 | |
| 2020 | |
| 2019 | |
| 2018 | |
| 2017 | |
| 2016 | |
| 2015 | |
| 2014 | |
Stocks
General information
-
Organization nameLabcorp Holdings Inc
-
Organization statusOperating organization
-
AddressC/O Treasury 531 South Spring Street Burlington, USA, 27215
-
Site
-
Previous organization nameLaboratory Corp of America Holdings (to 16/05/2024)
Codes
-
LEIOZ7UA8IXAIFILY2VZH07
-
SIC8071 SERVICES-MEDICAL LABORATORIES
-
CIK0000920148
-
EIN99-2588107









